Works matching IS 02724391 AND DT 2009 AND VI 70 AND IP 2

Results: 8

Translational medicine perspective in development of disease modifying therapies for Alzheimer's disease: biomarkers to buy down the risk.

Published in:

Drug Development Research, 2009, v. 70, n. 2, p. 60, doi. 10.1002/ddr.20292

By:

Wan, Hong I.;
Hurko, Orest;
Day, Mark;
Rutkowski, J. Lynn

Publication type:

Article

Progress toward the development of a viable BACE-1 inhibitor.

Published in:

Drug Development Research, 2009, v. 70, n. 2, p. 101, doi. 10.1002/ddr.20289

By:

Stachel, Shawn J.

Publication type:

Article

Structure and modeling in the design of β- and γ-secretase inhibitors.

Published in:

Drug Development Research, 2009, v. 70, n. 2, p. 70, doi. 10.1002/ddr.20291

By:

Holloway, M. Katharine;
Hunt, Peter;
McGaughey, Georgia B.

Publication type:

Article

γ-secretase inhibitors for the treatment of Alzheimer's disease.

Published in:

Drug Development Research, 2009, v. 70, n. 2, p. 94, doi. 10.1002/ddr.20288

By:

Wu, Wen-Lian;
Zhang, Lili

Publication type:

Article

Small molecule inhibitors of Aβ-aggregation and neurotoxicity.

Published in:

Drug Development Research, 2009, v. 70, n. 2, p. 111, doi. 10.1002/ddr.20290

By:

Hawkes, Cheryl A.;
Ng, Vivian;
McLaurin, JoAnne

Publication type:

Article

Advances in the development of kinase inhibitor therapeutics for Alzheimer's disease.

Published in:

Drug Development Research, 2009, v. 70, n. 2, p. 125, doi. 10.1002/ddr.20287

By:

Savage, Mary J.;
Gingrich, Diane E.

Publication type:

Article

5-HT<sub>6</sub> antagonists as potential treatment for cognitive dysfunction.

Published in:

Drug Development Research, 2009, v. 70, n. 2, p. 145, doi. 10.1002/ddr.20293

By:

Liu, Kevin G.;
Robichaud, Albert J.

Publication type:

Article

Alzheimer's disease: a light at the end of the tunnel?

Published in:

Drug Development Research, 2009, v. 70, n. 2, p. 57, doi. 10.1002/ddr.20286

By:

Robichaud, Albert J.;
Rotella, David P.

Publication type:

Article